MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Medical device titan Medtronic (NYSE:MDT) regained its seat at the top in September, making headlines with news of a possible deadly brain disease outbreak in Massachusetts that forced the company to track some rented neurosurgical tools.
Covidien (NYSE:COV) took the 2nd-place ribbon, having released its fiscal 2014 outlook and announced some layoffs in the near future. Boston Scientific (NYSE:BSX) jumped up to 3rd place with a warning on some implant batteries, a new Wall Street high and some legal announcements.
St. Jude Medical (NYSE:STJ) rejoined the list with European Union approval for its next-generation renal denervation system and some good news from sponsored companies. Johnson & Johnson (NYSE:JNJ) rounded out the top 5, mostly on news from its DePuy Synthes subsidiary.
Medtronic
- Medtronic launches hospital solutions arm, touts 1st cath-lab management deals
- ESC 2013: Medtronic’s Symplicity hypertension treatment still promising at 1 and 3 years
- Medtronic opens doors on innovation center in Singapore
- Medtronic: Rented surgical kit may have been contaminated with fatal brain disease
- UPDATE: Medtronic traces surgical kit possibly contaminated with fatal brain disease
- Medtronic seeks FDA update on all approved pacemakers and defibrillators
- Appeals court upholds Medtronic win over Gore in stent graft suit
- Medtronic wants Arizona judge to reconsider Infuse ruling
- Medtronic, Boston Scientific tout new centers overseas
- Medtronic CEO unloads 10k shares
- Medtronic wins a round in patent spat with Edwards Lifesciences
- Medtronic touts AdaptivCRT data on atrial fibrillation
- Medtronic pays $290k to settle wage discrimination lawsuit
- Medtronic lands extended FDA approval for Complete SE vascular stent
- Stryker, Medtronic lose preemption bids in OP-1, Calstrux and Infuse lawsuit
- Diabetes: Insulet inks $10M settlement deal with Medtronic
- Diabetes: Medtronic wins FDA approval for ‘artificial pancreas’ device, reveals warning letter
- Medtronic details diabetes facility warning letter
Covidien
- Covidien details fiscal 2014 outlook
- Covidien sued for patent infringement of valve disinfection systems
- Layoffs ahead for Covidien
- Ivera lobs another lawsuit at Covidien
Boston Scientific
- Boston Scientific hits 4-year high following asthma treatment trial results
- Boston Scientific pledges $600k for GI research
- Boston Scientific closes enrollment in Synergy stent trial
- Boston Scientific settles stent patent spat with OrbusNeich
- Pacemaker inventor’s family sues Boston Scientific for $570M
- Medtronic, Boston Scientific tout new centers overseas
- Boston Scientific warns on battery issues in certain implantable defibrillators
- Ireland finance chief denies Abbott, Boston Scientific paid little in taxes
St. Jude Medical
- Hypertension: St. Jude Medical lands EU approval for next-gen EnligHTN
- St. Jude-backed Spinal Modulation enrolls 1st patient in pain management study
- CardioMEMs’ 2nd chance with the FDA is good news for backer St. Jude Medical
- Appeals court reverses St. Jude Medical win over Access Closure
Johnson & Johnson
- Philips, J&J land Defense Dept. contracts worth up to $73M
- Prosecutors say DePuy hid risks in ASR hip recall
- Breast implants: Sientra touts legal win against Johnson & Johnson
- Johnson & Johnson shops Ortho Clinical Diagnostics unit
- Judge delays 1st bellwether DePuy ASR trial
- DePuy hip implant class action lawsuits spread north of the border
- DePuy ASR bellwether trial delayed again
